Biomedical Engineering Reference
In-Depth Information
65. J. Ferin, G. Oberdörster, D.P. Penney, S.C. Soderholm, R. Gelein, H.C. Piper, Increased pulmonary toxic-
ity of ultrafine particles? I. Particle clearance, translocation, morphology,
Journal of Aerosol Science
, 21,
1990, 381-384.
66. G. Oberdörster, J. Ferin, G. Finkelstein, P. Wade, N. Corson, Increased pulmonary toxicity of ultrafine
particles? II. Lung lavage studies,
Journal of Aerosol Science
, 21, 1990, 384-387.
67. G. Oberdürster, Toxicology of ultrafine particles:
In vivo
studies,
Philosophical Transactions of the Royal
Society of London. Series A: Mathematical, Physical and Engineering Sciences
, 358, 2000, 2719-2740.
68. S. Xiong, S. George, H. Yu, R. Damoiseaux, B. France, K. Ng, J.-C. Loo, Size influences the cytotox-
icity of poly (lactic-co-glycolic acid) (PLGA) and titanium dioxide (TiO
2
) nanoparticles,
Archives of
Toxicology
, 87, 2013, 1075-1086.
69. S. Akhtar, B. Chandrasekhar, S. Attur, M.H.M. Yousif, I.F. Benter, On the nanotoxicity of PAMAM den-
drimers: Superfect
®
stimulates the EGFR-ERK1/2 signal transduction pathway via an oxidative stress-
dependent mechanism in HEK 293 cells,
International Journal of Pharmaceutics
, 448, 2013, 239-246.
70. M.S. Lee, N.W. Kim, K. Lee, H. Kim, J.H. Jeong, Enhanced transfection by antioxidative polymeric gene
carrier that reduces polyplex-mediated cellular oxidative stress,
Pharmaceutical Research
, 2013, 1-10.
71. T.G. Park, J.H. Jeong, S.W. Kim, Current status of polymeric gene delivery systems,
Advanced Drug
Delivery Reviews
, 58, 2006, 467-486.
72. G. Grandinetti, N.P. Ingle, T.M. Reineke, Interaction of poly (ethylenimine)-DNA polyplexes with mito-
chondria: Implications for a mechanism of cytotoxicity,
Molecular Pharmaceutics
, 8, 2011, 1709-1719.
73. N. Li, C. Sioutas, A. Cho, D. Schmitz, C. Misra, J. Sempf, M. Wang, T. Oberley, J. Froines, A. Nel,
Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage,
Environmental Health
Perspectives
, 111, 2003, 455.
74. P. Borm, F.C. Klaessig, T.D. Landry, B. Moudgil, J. Pauluhn, K. Thomas, R. Trottier, S. Wood, Research
strategies for safety evaluation of nanomaterials, part V: Role of dissolution in biological fate and effects
of nanoscale particles,
Toxicological Sciences
, 90, 2006, 23-32.
75. A. Nel, T. Xia, L. Mädler, N. Li, Toxic potential of materials at the nanolevel,
Science
, 311, 2006,
622-627.
76. D.R. Boverhof, R.M. David, Nanomaterial characterization: Considerations and needs for hazard assess-
ment and safety evaluation,
Analytical and Bioanalytical Chemistry
, 396, 2010, 953-961.
77. R. Zini, P. Riant, J. Barré, J.-P. Tillement, disease-induced variations in plasma protein levels,
Clinical
Pharmacokinetics
, 19, 1990, 218-229.
78. J. McElnay, P. D'Arcy, Protein binding displacement interactions and their clinical importance,
Drugs
,
25, 1983, 495-513.
79. T.R. Nurkiewicz, D.W. Porter, A.F. Hubbs, J.L. Cumpston, B.T. Chen, D.G. Frazer, V. Castranova,
Nanoparticle inhalation augments particle-dependent systemic microvascular dysfunction,
Particle and
Fibre Toxicology,
5, 2008, 1-12.
80. N. Schöler, H. Hahn, R. Müller, O. Liesenfeld, Effect of lipid matrix and size of solid lipid nanoparticles
(SLN) on the viability and cytokine production of macrophages,
International Journal of Pharmaceutics
,
231, 2002, 167-176.
81. E. Bermudez, J.B. Mangum, B.A. Wong, B. Asgharian, P.M. Hext, D.B. Warheit, J.I. Everitt, Pulmonary
responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles,
Toxicological Sciences
, 77, 2004, 347-357.
82. J. Ferin, G. Oberdorster, D. Penney, Pulmonary retention of ultrafine and fine particles in rats,
American
Journal of Respiratory Cell and Molecular Biology
, 6, 1992, 535-542.
83. D.B. Warheit, W.J. Brock, K.P. Lee, T.R. Webb, K.L. Reed, Comparative pulmonary toxicity inhalation
and instillation studies with different TiO
2
particle formulations: Impact of surface treatments on particle
toxicity,
Toxicological Sciences
, 88, 2005, 514-524.
84. D.B. Warheit, T.R. Webb, K.L. Reed, S. Frerichs, C.M. Sayes, Pulmonary toxicity study in rats with three
forms of ultrafine-TiO2
2
particles: Differential responses related to surface properties,
Toxicology
, 230,
2007, 90-104.
85. D.B. Warheit, How meaningful are the results of nanotoxicity studies in the absence of adequate material
characterization?
Toxicological Sciences
, 101, 2008, 183-185.
86. R.S. Yang, L.W. Chang, J.P. Wu, M.H. Tsai, H.J. Wang, Y.C. Kuo, T.K. Yeh, C.S. Yang, P. Lin, Persistent
tissue kinetics and redistribution of nanoparticles, quantum dot 705, in mice: ICP-MS quantitative assess-
ment,
Environmental Health Perspectives
, 115, 2007, 1339-1343.
87. R. Singh, D. Pantarotto, L. Lacerda, G. Pastorin, C. Klumpp, M. Prato, A. Bianco, K. Kostarelos,
Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube
